Skip to content

8-KAccepted Nov 16, 6:58 AM ET

Vycor Medical Inc: reports results for three and nine months ended Sep 30, 2026

VYCOVYCOR MEDICAL INC

Accepted (ET)

6:58 AM

Nov 16, 2026

Filed

Nov 16, 2026

Documents

13

Size

361.9 KB

Summary

Vycor Medical Inc: reports results for three and nine months ended Sep 30, 2026

Updated

What happened

  • Vycor Medical Inc reported that on Nov 13, 2026 it issued a press release regarding its financial results for the three and nine months ended Sep 30, 2026. The press release is furnished as Exhibit 99.1 to this Form 8-K.
  • The Form 8-K states the Item 2.02 information is furnished and "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference" except by specific reference.

Key details

  • Press release issued on Nov 13, 2026 and furnished as Exhibit 99.1 to the Form 8-K.
  • Reporting period: the three and nine months ended Sep 30, 2026.
  • The press release includes non-GAAP Cash Operating Expenses and non-GAAP Cash Operating Loss measures that exclude Depreciation and non-cash Stock Compensation.
  • The press release provides a reconciliation of those non-GAAP measures to the comparable GAAP financial measures and states limitations of the non-GAAP measures (not prepared in accordance with GAAP; may differ from non-GAAP measures used by other companies; should not be considered in isolation or as a substitute for GAAP measures).

Why it may matter

  • Item 2.02 was reported (results of operations and financial condition), and Item 9.01 is present for exhibits (the press release is furnished as Exhibit 99.1).
  • The filing states the company used and reconciled certain non-GAAP measures and described their limitations and intended use in comparing operating results.
  • This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing